𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1

✍ Scribed by Owen T-Y Tsang; Jonpaul S-T Zee; Jacky M-C Chan; Reggie S-T Li; Yee-Man Kan; Francis T-W Li; Fu-Hang Lo; David A Chow; Kent W-L Cheung; Kam-Hon Chan; Yat-Wah Yeung; Fook-Hong Ng; Michael K-K Li; Wai-Keung Kwan; Thomas S-T Lai

Book ID
108952587
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
159 KB
Volume
25
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Merimepodib, pegylated interferon, and r
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders
✍ Vinod K. Rustgi; William M. Lee; Eric Lawitz; Stuart C. Gordon; Nezam Afdhal; Fr πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 240 KB πŸ‘ 1 views

on behalf of the MErimepodib TRiple cOmbination (METRO) study group Merimepodib (MMPD) is an orally administered, inosine monophosphate dehydrogenase inhibitor that has shown antiviral activity in nonresponders with chronic hepatitis C (CHC) when combined with pegylated interferon alfa 2a (Peg-IFN-a

Pegylated interferon and ribavirin thera
Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
✍ F. Legrand-Abravanel; F. Nicot; A. Boulestin; K. Sandres-SaunΓ©; J.P. Vinel; L. A πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 91 KB

## Abstract Hepatitis C Virus (HCV) is classified into six genotypes. Genotype 4 is now spreading in Europe, especially among drug users, who are often infected with both HCV and the human immunodeficiency virus (HIV). Previous studies have shown that HCV‐4 responds poorly to interferon. Pegylated

HBV genotype B is associated with better
HBV genotype B is associated with better response to interferon therapy in HBeAg( + ) chronic hepatitis than genotype C
✍ Chun Tao Wai; Chi-Jen Chu; Munira Hussain; Anna S. F. Lok πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 579 KB

Hepatitis B virus (HBV) genotype and precore/core promoter mutations have been implicated in spontaneous and interferon alfa (IFN-+related hepatitis B e antigen (HBeAg) seroconversion. We performed a retrospective analysis of a previously reported randomized controlled trial to determine the effects

Response to pegylated interferon alfa-2a
Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4
✍ Hesham El Makhzangy; Gamal Esmat; Mohamed Said; Maissa ElRaziky; Soheir Shouman; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 91 KB

## Abstract The safety and efficacy of pegylated interferon (PEG‐IFN) alfa‐2a and ribavirin were studied among patients treated for genotype 4 chronic hepatitis C. Ninety‐five patients with chronic hepatitis C genotype 4 were treated with PEG‐IFN alfa‐2a (180 ¡g/week) plus ribavirin (β‰₯11 mg/kg/day)